Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

32 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A Randomized Crossover Trial to Compare Automated Insulin Delivery (the Artificial Pancreas) With Carbohydrate Counting or Simplified Qualitative Meal-Size Estimation in Type 1 Diabetes.
Haidar A, Legault L, Raffray M, Gouchie-Provencher N, Jafar A, Devaux M, Ghanbari M, Rabasa-Lhoret R. Haidar A, et al. Among authors: raffray m. Diabetes Care. 2023 Jul 1;46(7):1372-1378. doi: 10.2337/dc22-2297. Diabetes Care. 2023. PMID: 37134305 Free PMC article. Clinical Trial.
Comparison Between Closed-Loop Insulin Delivery System (the Artificial Pancreas) and Sensor-Augmented Pump Therapy: A Randomized-Controlled Crossover Trial.
Haidar A, Legault L, Raffray M, Gouchie-Provencher N, Jacobs PG, El-Fathi A, Rutkowski J, Messier V, Rabasa-Lhoret R. Haidar A, et al. Among authors: raffray m. Diabetes Technol Ther. 2021 Mar;23(3):168-174. doi: 10.1089/dia.2020.0365. Epub 2020 Dec 31. Diabetes Technol Ther. 2021. PMID: 33050728 Free PMC article. Clinical Trial.
A Randomized Crossover Pilot Study Evaluating Glucose Control During Exercise Initiated 1 or 2 h After a Meal in Adults with Type 1 Diabetes Treated with an Automated Insulin Delivery System.
Myette-Côté É, Molveau J, Wu Z, Raffray M, Devaux M, Tagougui S, Rabasa-Lhoret R. Myette-Côté É, et al. Among authors: raffray m. Diabetes Technol Ther. 2023 Feb;25(2):122-130. doi: 10.1089/dia.2022.0338. Epub 2022 Dec 6. Diabetes Technol Ther. 2023. PMID: 36399114 Free PMC article. Clinical Trial.
Remission of Type 2 Diabetes Following a Short-term Intensive Intervention With Insulin Glargine, Sitagliptin, and Metformin: Results of an Open-label Randomized Parallel-Design Trial.
McInnes N, Hall S, Hramiak I, Sigal RJ, Goldenberg R, Gupta N, Rabasa-Lhoret R, Braga M, Woo V, Sultan F, Otto R, Smith A, Sherifali D, Liu YY, Gerstein HC; REMIT-sita Collaborative Group. McInnes N, et al. Diabetes Care. 2022 Jan 1;45(1):178-185. doi: 10.2337/dc21-0278. Diabetes Care. 2022. PMID: 34728531 Clinical Trial.
Prevalence of chronic kidney disease in France: methodological considerations and pitfalls with the use of Health claims databases.
Couchoud C, Raffray M, Lassalle M, Duisenbekov Z, Moranne O, Erbault M, Lazareth H, Parmentier C, Guebre-Egziabher F, Hamroun A, Metzger M, Mansouri I, Goldberg M, Zins M, Bayat-Makoei S, Kab S. Couchoud C, et al. Among authors: raffray m. Clin Kidney J. 2024 Apr 23;17(5):sfae117. doi: 10.1093/ckj/sfae117. eCollection 2024 May. Clin Kidney J. 2024. PMID: 38774439 Free PMC article.
[REIN: a tool at the service of the patients].
Ayav C, Raffray M, Béchade C, Couchoud C. Ayav C, et al. Among authors: raffray m. Nephrol Ther. 2023 Aug 28;18(S2):54-58. doi: 10.1016/S1769-7255(22)00569-7. Nephrol Ther. 2023. PMID: 37638510 French.
32 results